Vivoryon Therapeutics N.V. approved the appointment of Frank Weber, MD, and Anne Doering, CFA, to the Company's Board as executive directors.
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
0.655 EUR | -13.01% | -9.03% | -91.95% |
Apr. 24 | Transcript : Vivoryon Therapeutics N.V., 2023 Earnings Call, Apr 24, 2024 | |
Mar. 15 | Vivoryon Therapeutics N.V Announces Resignation of Board of Directors | CI |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-91.95% | 21.03M | |
+1.41% | 42.86B | |
+11.78% | 42.74B | |
+44.98% | 41.36B | |
-8.83% | 27.68B | |
+8.19% | 25.15B | |
-22.91% | 18.63B | |
+30.49% | 12.37B | |
-2.12% | 11.92B | |
+7.44% | 11.21B |
- Stock Market
- Equities
- VVY Stock
- News Vivoryon Therapeutics N.V.
- Vivoryon Therapeutics N.V. Announces Board Appointments